SAFETY AND EFFECTIVENESS OF UPADACITINIB OR ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 48 WEEKS FROM THE SELECT-COMPARE STUDY Fleischmann, R., Enejosa, J., Song, I., Mysler, E., Bessette, L., Peterfy, C., Durez, P., Ostor, A., Li Yihan, Zhou, Y., Genovese, M. C. BMJ PUBLISHING GROUP. 2019: 744–45

View details for DOI 10.1136/annrheumdis-2019-eular.4258

View details for Web of Science ID 000472207102190